Similar articles

• [Introduction: recent progress in therapy of prostatic carcinoma and other hormone dependent pathology with the use of agonistic analogs of LHRH].

  Bertelli A. Bertelli A. Drugs Exp Clin Res. 1990;16 Suppl:1-2. Drugs Exp Clin Res. 1990. PMID: 2081448 Italian. No abstract available.
• Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer.

  Nicholson RI, Walker KJ, Davies P. Nicholson RI, et al. Cancer Surv. 1986;5(3):463-86. Cancer Surv. 1986. PMID: 3555778 Review. No abstract available.
• [The use of GNRH analogs in the treatment of hormone dependent tumors].

  Zakut H, Birkenfeld S, Krispin M, Naor Z, Zilberstein M. Zakut H, et al. Harefuah. 1984 May 15;106(10):477-9. Harefuah. 1984. PMID: 6381259 Hebrew. No abstract available.
• [LHRH analogs as monthly depot preparations in treatment of advanced prostate cancer].

  [No authors listed] [No authors listed] Urologe A. 1991 May;30(3 Suppl):2-3. Urologe A. 1991. PMID: 1746071 German. No abstract available.
• [Clinical significance of LHRH and its analogs].

  Smals AG. Smals AG. Ned Tijdschr Geneeskd. 1985 Jan 5;129(1):15-20. Ned Tijdschr Geneeskd. 1985. PMID: 2857478 Review. Dutch. No abstract available.